David Mulligan

Professor and Chair, Transplantation and Immunology

Yale University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Mulligan is a Professor and Chair of Transplantation and Immunology at Yale School of Medicine, located in the United States. His research focuses on organ transplantation, including liver and kidney transplantation, and the associated clinical and ethical considerations. Recent publications include investigations into organ procurement networks and the impact of COVID-19 on organ donation and transplantation practices.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Christopher Watson

Professor of Transplantation

University of Cambridge

UNITED KINGDOM

View details

Daniela Ladner

Full Professor

Northwestern Medicine

UNITED STATES

View details

Nicolas Goldaracena

UNITED STATES

View details

Dixon Kaufman

Professor of Surgery

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Mulligan

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

CON: A multi-vendor organ procurement and transplantation network (OPTN) will not improve liver procurement and use

A Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report

Honoring the gift: The transformative potential of transplant-declined human organs

Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference

Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western Perspective

Inactive status is an independent predictor of liver transplant waitlist mortality and is associated with a transplant centers median meld at transplant

Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy

The demise of islet allotransplantation in the United States: A call for an urgent regulatory update

The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement

Deceased donors: Defining drug-related deaths

Fibronodular hepatocellular carcinoma - A new variant of liver cancer: Clinical, pathological and radiological correlation

Collaborators (4)

Christopher Watson

Daniela Ladner

Nicolas Goldaracena

Dixon Kaufman

Make your next move.